title: Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese.
abstract: We typed 247 cases of nasopharyngeal carcinoma (NPC), a disease predominantly of the southern Chinese, and 274 controls from the Chao Shan region of China's Guangdong province for HLA A and B. Besides confirming the established associations with A2, A33, B46 and B58 (positive associations) and A11 (negative association), the results demonstrated a number of rarer alleles with strong negative association with NPC. Our data, combined with those from the previous studies in Southern Chinese, displayed the protective effects for A31 (odds ratio (OR)=0.0; 95% confidence interval (CI)=0-0.11), B13 (OR=0.50; 95% CI=0.35-0.69), B27 (OR=0.49; 95% CI=0.25-0.92), B39 (OR=0.18; 95% CI=0.06-0.48) and B55 (OR=0.32; 95% CI=0.14-0.68), the ORs comparing individuals with or without each allele. Other ethnic groups do not display such large HLA-associated variation in NPC risk. We show that a linked NPC gene with dominant mode of action could not generate such large protective effects. The results provide strong supporting evidence for the existence of a southern Chinese specific, recessive NPC gene closely linked to the HLA region as a major determinant of the Chinese risk for the disease.
authors.affiliation: Center for Molecular Biology, Shantou University Medical College, Xin Ling Road, Shantou 515031, People's Republic of China. sphu@stu.edu.cn
authors.forename: S P
authors.initials: SP
authors.lastname: Hu
authors.forename: N E
authors.initials: NE
authors.lastname: Day
authors.forename: D R
authors.initials: DR
authors.lastname: Li
authors.forename: R N
authors.initials: RN
authors.lastname: Luben
authors.forename: K L
authors.initials: KL
authors.lastname: Cai
authors.forename: T
authors.initials: T
authors.lastname: Ou-Yang
authors.forename: B
authors.initials: B
authors.lastname: Li
authors.forename: X Z
authors.initials: XZ
authors.lastname: Lu
authors.forename: B A J
authors.initials: BA
authors.lastname: Ponder
mesh_terms: D002681:China; D016001:Confidence Intervals; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D017931:DNA Primers; D005808:Genes, Recessive; D015234:HLA-A Antigens / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics*; D006650:Histocompatibility Testing; D008285:Major Histocompatibility Complex / Q000235:genetics*; D009303:Nasopharyngeal Neoplasms / Q000235:genetics*; D016017:Odds Ratio; D012016:Reference Values
chemical_list: D017931:DNA Primers; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D004247:DNA
references.citation: Tissue Antigens. 1983 Nov;22(5):335-41
references.pmid: 6419386
references.citation: Int J Cancer. 1994 Feb 15;56(4):465-7
references.pmid: 8112882
references.citation: Anticancer Res. 1989 Nov-Dec;9(6):1649-53
references.pmid: 2697183
references.citation: Int J Cancer. 1975 Aug 15;16(2):249-54
references.pmid: 1150352
references.citation: Lancet. 1975 Jan 18;1(7899):142-3
references.pmid: 46054
references.citation: Nature. 1990 Aug 2;346(6283):470-1
references.pmid: 2377207
references.citation: Methods Mol Biol. 2003;210:143-71
references.pmid: 12412454
references.citation: Zhonghua Zhong Liu Za Zhi. 1982 Nov;4(4):249-53
references.pmid: 7166103
references.citation: J Natl Cancer Inst. 2002 Dec 4;94(23):1780-9
references.pmid: 12464650
references.citation: Int J Cancer. 1983 Aug 15;32(2):171-6
references.pmid: 6874140
references.citation: IARC Sci Publ. 1980;(32):5-338
references.pmid: 7216345
references.citation: Tissue Antigens. 1995 Nov;46(5):355-67
references.pmid: 8838344
references.citation: Tissue Antigens. 1983 Jul;22(1):72-5
references.pmid: 6577695
references.citation: Int J Cancer. 2001 Apr 15;92(2):294-7
references.pmid: 11291059
references.citation: Int J Cancer. 2003 Mar 1;103(6):745-51
references.pmid: 12516093
references.citation: Nat Genet. 2002 Aug;31(4):395-9
references.pmid: 12118254
references.citation: Int J Cancer. 1997 Apr 22;74(2):229-32
references.pmid: 9133461